Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas

The aim of our study was to evaluate the association between the mammographic appearance and the biologic characteristics of high-grade breast carcinomas. Three hundred and twenty patients with breast carcinomas were studied. Histological examination showed 83 (26%) high-grade ductal carcinomas. Immunohistochemistry was carried out by using antibodies against estrogen receptor (ER), progesterone receptor (PR), HER-2/neu, p53 and cathepsin D. In 60/83 high-grade carcinomas we studied the mammographic appearance. Asymmetric density with poorly defined margins without microcalcifications was the major mammographic finding in 49/60 (approximately 82%) high-grade ductal carcinomas. HER-2/neu positivity (68.7%) and p53 positivity (48.2%) were statistically correlated with asymmetric density with poorly defined margins without microcalcifications in high-grade carcinomas. We observed loss of ER and PR receptors in 50%, whereas loss of PR receptors was observed in 65% of high-grade breast carcinomas. Cathepsin D (> 20%) was detected in 38.5% of high-grade carcinomas. Our findings suggest a significant relationship between mammographic appearance and biologic markers in high-grade breast carcinomas.

Breast carcinoma; Mammographic appearance; Molecular prognostic factors

[1] Cowan W.K., Kelly P., Sawan A. et al.: "The pathological and b10-logical nature of screen-detected breast carcinomas. A morphological and Immunohistochemical study". J. Pathol., 1997, 182, 29.

[2] Moezzi M., Melamed J., Vamvakas E. et al.: "Morphological and biological characteristics of mammogram-detected invasive breast cancer". Human Pathol., 1996, 27,944.

[3] Karamouzis M.V., Likaki-Karatza E., Ravazoula P. et al.: "Nonpalpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors". Int. J. Cancer, 2002, 102, 86.

[4] Henry J.A., McCarthy A.L., Angus B. et al.: "Prognostic significance of the estrogen-regulated protein Cathepsin D, in breast cancer: an Immunohistochemical study". Cancer, 1990, 65, 265.

[5] Cowan W.K., Angus B., Henry J. et al.: "lmmunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening". Br. J. Cancer, 1991, 64, 780.

[6] Porter P.L.,G own A.M., Kramp S.G.,C oltera M.D.: "Widespread p53 overexpression in human malignant tumors". Am. J. Pathol., 1992, 140, 1453.

[7] Dawson A.E., Norton J.A., Weinberg D.S.: "Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry". Am. J. Pathol., 1990, 136, 1115.

[8] Harris J.R., Hellmans S., Canellos G.P., Fischer B.: "Cancer of the breast". In: DeVita VT. Jr., Hellman S., Rosenberg S.A. (eds.). Cancer: Principles and Practice of Oncology. 2''edition, Vol 2. Philadelphia, JP Lippincott 1985, 1119.

[9] Clark G.M., McGuire W.L.: "Steroid receptors and other prognostic factors in primary breast cancer". Semin. Oneal., 1988, 15, 20.

[10] Tsutsui S., Ohno S., Murakami S. et al.: "Prognostic value of cerbB-2 expression in breast cancer". J Surg. Oneal., 2002, 79, 216.

[11] Chung Y.L., Sheu M.L., Yang S.C., Lin C.H., Yen C.V.: "Resistance to tamoxifen-indused apoptosis is associated with direct interaction between Her-2/neu and cell membrane estrogen receptor in breast cancer". Int. J. Cancer, 2002, 97, 306.

[12] Henry J.A., MacGarthy A.L., Angus B. et al.: "Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer". Cancer, 1990, 65, 265.

[13] Armas 0.A., Gerald W.L., Lesser M.L. et al.: "Immunohistochemical detection of cathepsin D in T2NOMO breast carcinoma". Am. J. Surg. Pathol., 1994, 18, 158.